Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02283385 · ClinicalTrials.gov registry record · NA

Mental Health Intervention for Elderly Abuse Victims

A NA study of Depression, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
NA
Development phase
63
Enrollment target
2
Study locations

NCT02283385: Completed NA study of Depression, sponsored by Weill Medical College of Cornell University.

NCT02283385 is a NA study of Depression that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 63 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02283385, a NA study of Depression, has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
NA
Development phase
63 participants
Enrollment target
2
Study locations

Study Summary

There is no current elder abuse service that systematically assesses and provides services to address the mental health needs of older adult abuse victims. The proposed study will investigate the efficacy of a skill-based, mental health intervention to help treat elder abuse victims, bolster mental health outcomes, and improve detection of symptomatology in future screenings.

Primary Outcome

To document effectiveness of PROTECT intervention in reducing depressive symptoms. Severity of depression will be assessed at baseline and 12 weeks using the Hamilton Depression Rating Scale as the primary measure.

Conditions Studied

Interventions

  • BEHAVIORAL PROTECT

Study Locations (2)

New York

  • Department for the Aging: Elderly Crime Victims Resource Center - New York
  • Jewish Association Serving the Aging - New York

Trial Details

FieldValue
Enrollment Target 63 participants
Start Date 2014-07
Est. Completion 2017-06-30
Phase NA

What the finished NCT02283385 record still lists

NCT02283385 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 63 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (92% lower).

The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 1 intervention - of which PROTECT is the first listed.

NCT02283385 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT02283385 about?

NCT02283385 is a clinical study titled "Mental Health Intervention for Elderly Abuse Victims". There is no current elder abuse service that systematically assesses and provides services to address the mental health needs of older adult abuse victims. The proposed study will investigate the efficacy of a skill-based, mental health intervention to help treat elder abuse victims, bolster mental ...

What is the current status of trial NCT02283385?

This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2014-07. Estimated completion is 2017-06-30.

What conditions does trial NCT02283385 study?

This clinical trial studies the following conditions: Depression.

What interventions are being tested in trial NCT02283385?

The interventions under investigation include: PROTECT (BEHAVIORAL).

Who is sponsoring clinical trial NCT02283385?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02283385 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02283385's enrollment target sits among peer trials

63 426th of 679 higher than 253 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03383575 · 63 participants · Phase 2

    Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome

  • NCT04870944 · 63 participants · Phase 1

    CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

  • NCT05031897 · 63 participants · Phase 2

    Two Step Haplo With Radiation Conditioning

  • NCT05312671 · 63 participants · Phase 2

    Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02283385, the US trial registry maintained by the National Library of Medicine. NCT02283385 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.